KZA
Click for more information
0.00% 8.0¢ kazia therapeutics limited

novogen corporate focus article in the afr, page-8

  1. munch
    3,567 Posts.
    clock Created with Sketch.
    12/02/03
    10:33
    Post #: 123680
    Yes to both counts.

    Trials are progressing well... there will be updates (at least for the Yale trial) before the trial is finished.

    I'm in the process of trying to find out more from the RNS trials.

    Also, expect some more trials to commence shortly.
    NRT Price at posting: 0.0¢ Sentiment: None Disclosure: Not Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

ENR Encounter Resources flags latest niobium hits in fresh assay data
right-arrow Created with Sketch.
MGT Magnetite Mines set to progress DFS for Razorback through deal with JFE Shoji
right-arrow Created with Sketch.
HCH Hot Chili sets up water company as drought racks Chile–but must also build communities a desal plant
right-arrow Created with Sketch.
CUV British study shows Clinuvel drug effective on DNA of UV-damaged skin
right-arrow Created with Sketch.
SXE SCEE boosts Synergy deal by $50M for Collie battery project
right-arrow Created with Sketch.
PMT High-grade lithium zone extended at Patriot's Corvette project, drilling grades at 5%
right-arrow Created with Sketch.
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.